Evidence map›Paper›PMID 24180271›Full record

ArticleJournal of the American Chemical Society2013

Stilbene vinyl sulfonamides as fluorogenic sensors of and traceless covalent kinetic stabilizers of transthyretin that prevent amyloidogenesis.

Eul Hyun Suh, Yu Liu, Stephen Connelly, Joseph C Genereux, Ian A Wilson, Jeffery W Kelly

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Spectral fine tuning of cyanine dyes: electron donor-acceptor substituted analogues of thiazole orange.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2015
    Article
  9. Article
  10. Article
  11. Article
  12. Small molecule probes to quantify the functional fraction of a specific protein in a cell with minimal folding equilibrium shifts.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Eul Hyun SuhDepartment of Chemistry, ‡The Skaggs Institute for Chemical Biology, §Department of Integrative Structural and Computational Biology, and ∥Department of Molecular and Experimental Medicine, The Scripps Research Institute , La Jolla, California 92037, United States.
Yu Liu
Stephen Connelly
Joseph C Genereux
Ian A Wilson
Jeffery W Kelly
Scripps Research Institute · US

Funding

ZWITTERION SURFACTANT DDMAB FOR IMPROV STABIL OF PROTEINP41RR001209 · NCRR · STANFORD UNIVERSITY · PI GONZALEZ, ANA M · 1985 to 2011
$38.9M
X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Probing the Biochemical Mechanisms of Amyloid DiseaseR01DK046335 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI KELLY, JEFFERY W · 1998 to 2025
$8.8M
Probing the biochemical mechanism of amyloid diseaseR37DK046335 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI KELLY, JEFFERY W · 2006 to 2015
$5.9M
Proteostasis Network Factors Involved in Apolipoprotein B Folding and SecretionF32HL099245 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI GENEREUX, JOSEPH · 2010 to 2012
$146k
BIOCHEMICAL MECHANISM OF AMYLOID DISEASER29DK046335 · NIDDK · TEXAS A&M UNIVERSITY SYSTEM · PI KELLY, JEFFERY W · 1993 to 1997
–
NCRR NIH HHS P41 RR001209NCRR NIH HHS P41RR001209NHLBI NIH HHS F32 HL099245NHLBI NIH HHS F32-HL099245NIDDK NIH HHS DK046335NIDDK NIH HHS R01 DK046335NIDDK NIH HHS R37 DK046335NIGMS NIH HHS P41 GM103393NIGMS NIH HHS P41GM103393
6 · The paper itself

Abstract

Small molecules that react selectively with a specific non-enzyme drug-target protein in a complex biological environment without displacement of a leaving group (tracelessly) are rare and highly desirable. Herein we describe the development of a family of fluorogenic stilbene-based vinyl amides and vinyl sulfonamides that covalently modify transthyretin (TTR) tracelessly. These small molecules bind selectively to TTR in complex biological environments and then undergo a rapid and chemoselective 1,4-Michael addition with the pKa-perturbed Lys-15 ε-amino group of TTR. Replacing the vinyl amide in 2 with the more reactive vinyl sulfonamide in 4 hastens the conjugation kinetics. X-ray cocrystallography verified the formation of the secondary amine bond mediating the conjugation in the case of 2 and 4 and confirmed the expected orientation of the stilbene within the TTR binding sites. Vinyl amide 2 and vinyl sulfonamide 4 potently inhibit TTR dissociation and amyloid fibril formation in vitro. The TTR binding selectivity, modification yield, and reaction chemoselectivity of vinyl sulfonamide 4 are good enough in human plasma to serve as a starting point for medicinal chemistry efforts. Moreover, vinyl sulfonamide 4 is fluorogenic: it exhibits minimal background fluorescence in complex biological environments, remains dark upon binding to TTR, and becomes fluorescent only upon reaction with TTR. The fluorogenicity of 4 was utilized to accurately quantify the native TTR concentration in Escherichia coli lysate using a fluorescence plate reader.

Indexed as

AmidesAmyloidCrystallography, X-RayFluorescent DyesHumansKineticsModels, MolecularPrealbuminStilbenesSulfonamidesAmidesAmyloidFluorescent DyesPrealbuminStilbenesSulfonamidesvinyl sulfonamide

Identifiers

PMID24180271
PMCPMC3879133
OpenAlexW2127118152

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.